Synovus Financial Corp Decreases Position in iShares Biotechnology ETF (NASDAQ:IBB)

Synovus Financial Corp reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,777 shares of the financial services provider’s stock after selling 168 shares during the quarter. Synovus Financial Corp’s holdings in iShares Biotechnology ETF were worth $1,569,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BNP Paribas Financial Markets boosted its position in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. State of Michigan Retirement System grew its stake in iShares Biotechnology ETF by 150.0% during the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after purchasing an additional 75,000 shares in the last quarter. Aristides Capital LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $9,180,000. Finally, Sanctuary Advisors LLC purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $8,118,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB stock opened at $136.61 on Monday. The firm has a 50 day simple moving average of $141.84 and a 200-day simple moving average of $142.38. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.